Mari Odamaki

Suggest Changes
Learn More
BACKGROUND Inflammation is one of the major causes of resistance to erythropoietin (rHuEpo) treatment. Tumour necrosis factor-alpha (TNF-alpha), one of the most potent proinflammatory cytokines, is(More)